Results 111 to 120 of about 13,110 (173)

Evaluation of idiopathic olfactory dysfunction as a warning marker for early parkinson's disease: a population-based cross-sectional study. [PDF]

Sci Rep
Vedadi Z, Miandehi EE, Akbari M, Shoeibi A, Vedadi D, Eslami S, Taherzadeh Z.   +6 more
europepmc   +1 more source

Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism [PDF]

, 2016
Brooks, D.J., Chaudhuri, K R, Gafton, J., Pagano, G., Pavese, N., Shah, B., Taylor, S.   +6 more
core   +1 more source

Patient education regarding improving quality of sleep among diabetes patients: A cross-sectional study. [PDF]

J Educ Health Promot
Abdulrab RT, Hassan AF.
europepmc   +1 more source

Modafinil for Promoting Wakefulness in Critically Ill Patients: Current Evidence and Perspectives. [PDF]

Clocks Sleep
Kakavas S, Karayiannis D.
europepmc   +1 more source

Therapeutic Use of Melatonin for Gastrointestinal Motility and Hypersomnolence in a Patient With Pineal Cyst Pathology. [PDF]

Am J Case Rep
Cross AR, Van Liew JR, Thakkar P, Brunia A.   +3 more
europepmc   +1 more source

Can Sleep Quality be Associated With Positional Vertigo in Children With Dizziness? [PDF]

Brain Behav
Sahin BU, Soylemez TG, Ertugrul G.
europepmc   +1 more source

Sleep disorders. Part II: Disorders of excessive somnolence.

North Carolina medical journal, 1982
openaire   +1 more source

The Relationship Between ADHD Symptom Severity and Sleep Disturbance Using Accelerometer and the Subjective Sleep Disturbance Scale. [PDF]

J Atten Disord
Patel B, Tyrka A, Lewis-de Los Angeles W.   +2 more
europepmc   +1 more source

Evaluation of Sleep Disturbances and Depression in Children with Juvenile Idiopathic Arthritis Using the Beck Depression Inventory and Child Sleep Disorder Scale: Relationship with Leukocyte and Neutrophil Counts. [PDF]

Children (Basel)
Dogantan S, İlter Bahadur E, Bozkaya Yücel B, Keskin A, Bekece E.   +4 more
europepmc   +1 more source

Adverse event reporting of mirtazapine: A disproportionality analysis of FDA adverse event reporting system (FAERS) database from 2004-2024. [PDF]

PLoS One
Guo K, Li H, Wang W, Cheng L, Du W, Zhang J.   +5 more
europepmc   +1 more source